Granite Point Capital Management, L.P. Deciphera Pharmaceuticals, Inc. Transaction History

Granite Point Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 12, 2020	SELL	$33.63 - $69.4 $1.41 Million - $2.91 Million	-42,000 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$19.95 - $38.85 $837,900 - $1.63 Million	42,000 New	42,000 $1.43 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.